文献速递骨肌泌尿生殖MRCTDXA

低强度振动改善终末期肾病患者骨骼健康的疗效高度依赖于依从性和肌肉反应

The Efficacy of Low-intensity Vibration to Improve Bone Health in Patients with End-stage Renal Disease Is Highly Dependent on Compliance and Muscle Response.
PubMed 文献 · Acad Radiol · 2017-06-23

30例维持性血液透析的终末期肾病患者随机分为活性或安慰剂低强度振动装置组,每日站立20分钟,干预6个月。意向性治疗分析未显示低强度振动相关的显著变化;依从性高于中位数(70%)的活性装置使用者出现远端胫骨硬度增加5.3%、骨小梁数量增加1.7%、骨密度增加2.3%、板杆比增加6.5%、骨小梁分离度降低1.8%;活性组小腿肌肉横截面积变化与远端胫骨硬度等指标相关,而安慰剂组无此相关。

要点

  • 意向性治疗分析未显示低强度振动对终末期肾病患者骨骼结局有显著改善。
  • 依从性超过中位数70%的活性装置使用者出现远端胫骨硬度增加5.3%等骨微结构改善。
  • 活性组小腿肌肉横截面积变化与远端胫骨硬度相关(R=0.85),安慰剂组无此相关。

核心结论

  • 意向性治疗分析未显示低强度振动相关的显著变化;依从性高于中位数(70%)的活性装置使用者出现远端胫骨硬度增加5.3%、骨小梁数量增加1.7%、骨密度增加2.3%、板杆比增加6.5%、骨小梁分离度降低1.8%;活性组小腿肌肉横截面积变化与远端胫骨硬度(R=0.85)、骨小梁骨体积/总体积(R=0.91)、数量(R=0.92)和分离度(R=-0.94)相关,而安慰剂组无此相关;安慰剂组基线甲状旁腺激素水平与6个月研究期间皮质骨孔隙率增加正相关(R=0.55),活性组无此相关(R=0.01);除安慰剂组髋部骨密度降低1.7%外,两组非远端胫骨部位未见变化。

研究设计与样本

  • 随机对照试验(活性低强度振动装置 vs 安慰剂装置),30例维持性血液透析的终末期肾病患者,每日站立20分钟,干预6个月;基线及完成时评估包括磁共振成像(胫骨和腓骨硬度、骨小梁厚度、数量、分离度、骨体积分数、板杆比、皮质骨孔隙率)、双能X射线吸收测定法(髋部和脊柱骨密度)和外周定量计算机断层扫描(胫骨骨小梁和皮质骨密度、小腿肌肉横截面积)。

关键影像表现/征象

  • 磁共振成像评估胫骨和腓骨硬度、骨小梁厚度、数量、分离度、骨体积分数、板杆比及皮质骨孔隙率。
  • 双能X射线吸收测定法评估髋部和脊柱骨密度。
  • 外周定量计算机断层扫描评估胫骨骨小梁和皮质骨密度及小腿肌肉横截面积。

诊断标准与关键数值

  • 意向性治疗分析未显示低强度振动相关的任何显著结局变化。
  • 活性装置且依从性大于中位数(70%)者:远端胫骨硬度增加5.3%、骨小梁数量增加1.7%、骨密度增加2.3%、板杆比增加6.5%、骨小梁分离度降低1.8%。
  • 活性组小腿肌肉横截面积变化与远端胫骨硬度相关(R=0.85)、与骨小梁骨体积/总体积相关(R=0.91)、与骨小梁数量相关(R=0.92)、与骨小梁分离度相关(R=-0.94);安慰剂组无此相关。
  • 安慰剂组基线甲状旁腺激素水平与6个月研究期间皮质骨孔隙率增加正相关(R=0.55),活性组无此相关(R=0.01)。
  • 安慰剂组髋部骨密度降低1.7%;两组非远端胫骨部位未见其他变化。

临床应用与阅片要点

  • 本 pilot 研究识别出的结局和依从性阈值可指导未来涉及振动疗法的纵向研究。

局限性

  • 本 pilot 研究识别出的结局和依从性阈值可指导未来涉及振动疗法的纵向研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONAL AND OBJECTIVES: Low intensity vibration (LIV) may represent a nondrug strategy to mitigate bone deficits in patients with end-stage renal disease.

MATERIALS AND METHODS: Thirty end-stage renal patients on maintenance hemodialysis were randomized to stand for 20 minutes each day on either an active or placebo LIV device. Analysis at baseline and completion of 6-month intervention included magnetic resonance imaging (tibia and fibula stiffness; trabecular thickness, number, separation, bone volume fraction, plate-to-rod ratio; and cortical bone porosity), dual-energy X-ray absorptiometry (hip and spine bone mineral density [BMD]), and peripheral quantitative computed tomography (tibia trabecular and cortical BMD; calf muscle cross-sectional area).

RESULTS: Intention-to-treat analysis did not show any significant changes in outcomes associated with LIV. Subjects using the active device and with greater than the median adherence (70%) demonstrated an increase in distal tibia stiffness (5.3%), trabecular number (1.7%), BMD (2.3%), and plate-to-rod ratio (6.5%), and a decrease in trabecular separation (-1.8%). Changes in calf muscle cross-sectional area were associated with changes in distal tibia stiffness (R = 0.85), trabecular bone volume/total volume (R = 0.91), number (R = 0.92), and separation (R = -0.94) in the active group but not in the placebo group. Baseline parathyroid hormone levels were positively associated with increased cortical bone porosity over the 6-month study period in the placebo group (R = 0.55) but not in the active group (R = 0.01). No changes were observed in the nondistal tibia locations for either group except a decrease in hip BMD in the placebo group (-1.7%).

CONCLUSION: Outcomes and adherence thresholds identified from this pilot study could guide future longitudinal studies involving vibration therapy.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Rajapakse CS, Leonard MB, Kobe EA, et al. The Efficacy of Low-intensity Vibration to Improve Bone Health in Patients with End-stage Renal Disease Is Highly Dependent on Compliance and Muscle Response. Acad Radiol. 2017. PMID: 28652048. doi:10.1016/j.acra.2017.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。